KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS

/PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce a placement...

Related Keywords

Australia ,Sydney ,New South Wales ,Australian , ,Kazia Therapeutics Limited ,Australian Securities Exchange ,Nasdaq ,New Shares ,Unconditional Placement ,Conditional Placement ,Extraordinary General Meeting ,